Femtech startup Inne takes the wraps off a hormone tracker and $8.8M in funding
Post date: 2019-10-31 20:00:45
Views: 315
Berlin-based femtech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking and natural contraception that’s slated for launch in Q1 next year. The Series A is led by led by Blossom Capital, with early Inne backer Monkfish
Please click Here to read the full story.
 
Other Top and Latest Questions:
Buy this social media stock with lots of upside thanks to AI, says Evercore ISI
More drivers have $1,000-plus car loan payments. Here's what buyers can expect in 2026
Why Jim Cramer is bullish on Goldman Sachs and Morgan Stanley
Rates have dropped to the lowest point in years — here are the best lenders for refinancing your mortgage
TSMC is set to expand its $165 billion U.S. investment — here’s what we know
OpenAI tells investors to brace for 'deliberately outlandish' claims from Musk ahead of trial
Trump's proposed ban on buying single-family homes introduces uncertainty for family offices
Here are Needham's top picks for 2026
Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more
Amazon threatens 'drastic' action after Saks bankruptcy, says $475M stake is now worthless